Skip to content

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers

Multilevel Intervention to Improve Follow-up Colonoscopy Rates After Abnormal FIT Results in Large FQHC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06568016
Enrollment
1500
Registered
2024-08-23
Start date
2025-04-22
Completion date
2029-08-31
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Carcinoma

Brief summary

This clinical trial evaluates a clinic-wide intervention called Primary Care-Gastrointestinal (GI) Connect for improving follow-up colonoscopy rates in patients at a Federally Qualified Health Center (FQHC) who have an abnormal fecal immunochemical test (FIT) result. Colorectal cancer screening reduces colorectal cancer incidence and mortality but is underutilized.The most accessible, feasible, and common colorectal cancer screening modality for average-risk individuals in low resource settings such as FQHCs is the stool-based FIT. However, the benefit of FIT screening on colorectal cancer risk is realized only if individuals with abnormal FIT results undergo timely follow-up colonoscopy. Follow-up colonoscopy rates are low and there are many barriers to follow-up colonoscopy in safety net settings such as FQHCs. Effective interventions that are multi-component and improve care coordination are needed to improve abnormal FIT follow-up rates in FQHCs. The Primary Care-GI Connect intervention includes components that enhance care coordination, standardize the referral process, and engage both primary care and specialist physicians. This clinic-wide intervention may improve rates of follow-up colonoscopy after abnormal FIT results in patients seen at FQHCs.

Detailed description

PRIMARY OBJECTIVES: I. Conduct a pragmatic, cluster randomized trial in 6 clinics (1500 patients) within a multi-site FQHC system to compare the effectiveness of the multilevel FQHC-GI care coordination intervention ("Primary Care-GI Connect "; 3 clinics, 750 patients) to the usual care condition (3 clinics, 750 patients) on receipt of a colonoscopy within 6 months of an abnormal FIT. II. Systematically assess the quality of intervention implementation to understand the feasibility and relative importance of intervention elements as guided by the Multilevel Health Outcomes Framework. III. Measure the incremental cost-effectiveness of the Primary Care-GI Connect intervention compared to usual care to understand the potential value, feasibility, and potential for dissemination. OUTLINE: Northeast Valley Health Corporation (NEVHC) clinics are randomized to 1 of 2 arms. ARM I: Patients receive clinical care consistent with current practice at NEVHC. Patients have their electronic health records (EHRs) reviewed monthly by the Primary Care FIT Tracker for abnormal FIT results and patients with abnormal FIT results receive standardized communication from FIT quality improvement (QI) champions about their results and receive a referral to gastroenterology. ARM II: Patients receive clinical care consistent with current practice at NEVHC as described in Arm I. Patients also receive enhanced GI care coordination from GI liaisons, who generate GI FIT Tracker reports and use the GI FIT Tracker reports to follow patients with abnormal FIT results. Patients receive navigation services including contact from GI liaisons about making a GI appointment and enhanced communication between GI specialists and the NEVHC. Patients receive referral to gastroenterology following a standardized referral template and receive colonoscopy education including an informational sheet at the time of referral and a 20-minute pre-colonoscopy educational video. Patients receive a text message at the time of colonoscopy referral emphasizing the importance of colonoscopy after abnormal FIT result.

Interventions

OTHERBest Practice

Receive clinical care consistent with current practice

OTHERCommunication Intervention

Receive standardized communication from FIT QI champion

Receive enhanced GI care coordination

OTHEREducational Intervention

Watch pre-colonoscopy educational video

OTHERElectronic Health Record Review

Undergo FIT result review by Primary Care FIT Tracker

OTHERInformational Intervention

Undergo generation and review of GI FIT Tracker report

OTHERInterview

Ancillary studies

BEHAVIORALPatient Navigation

Receive navigation from GI liaisons

Receive referral

Receive follow-up text message

Sponsors

Jonsson Comprehensive Cancer Center
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* 6 adult care NEVHC clinic sites

Design outcomes

Primary

MeasureTime frameDescription
Follow-up colonoscopy ratesAt 6 monthsEvaluated in patients with an abnormal fecal immunochemical test (FIT) result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion within 6 months (yes/no).
Implementation quality: fit trackerMonthly intervals up to 3 yearsThe Investigators will measure the percent of cases for which the FIT tracker is used, as well as its use for each step in the process. For these measures, we will also measure time to completion.
Implementation quality: patient notificationMonthly intervals up to 3 yearsThe Investigators will measure both the percent of patients who are notified of their abnormal results as well as the time to notification.
Implementation quality: patient referralMonthly intervals up to 3 yearsThe Investigators will measure the percent of patients who receive a referral.
Implementation quality: Time to patient referralMonthly intervals up to 3 yearsThe Investigators will measure the time to patient referral.
Implementation quality: use of referral template as percent completion of interventionsMonthly intervals up to 3 yearsThe Investigators will measure the percent completion of interventions for patients at each step.
Implementation quality: referral template in time to completionMonthly intervals up to 3 yearsThe Investigators will measure the time to completion of interventions.
Implementation quality: patient educationMonthly intervals up to 3 yearsThe Investigators will measure the percent of cases in which patient education is delivered.
Implementation quality: Patient attendance: completion of a pre-colonoscopy visitMonthly intervals up to 3 yearsThe Investigators will measure the percent of patients who complete a pre-colonoscopy visit.
Implementation quality: time to completion of a pre-colonoscopy visitMonthly intervals up to 3 yearsThe Investigators will measure the time to completion of a pre-colonoscopy visit.
Implementation quality: receipt of colonoscopy and pathology results at Northeast Valley Health CorporationMonthly intervals up to 3 yearsThe Investigators will measure the percent of patients for which colonoscopy and pathology results are received at NEVHC.
Implementation quality: receipt of colonoscopy and pathology results at Northeast Valley Health Corporation over timeMonthly intervals up to 3 yearsThe Investigators will measure the time to retrieval of colonoscopy and pathology results received at NEVHC.
Cost-effectivenessUp to 3 yearsWill use standard cost-effectiveness techniques (including time discounting) to conduct an incremental cost-effectiveness analysis, measuring the Incremental Cost-Effectiveness Ratio of the usual care and Primary-care GI connect intervention conditions.

Secondary

MeasureTime frameDescription
Time to colonoscopy0-24 monthsThe Investigators will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion.
Follow-up colonoscopy ratesAt 9 months and at 12 monthsEvaluated in patients with an abnormal FIT result using electronic health record data. Will use a difference-in-differences approach, assessing whether change in completion rates from baseline to the implementation period differs between the intervention and usual care conditions, thus accounting for potential differences among clinics pre-implementation. Will fit a mixed effects logistic regression model with a dependent variable of patient-level colonoscopy completion within 9 months (yes/no).
Factors associated with ImplementationAt pre-intervention (1-2 years) and at the implementation midpoint (3-4 years)The Investigators will use the Organizational Readiness to Implement Change tool to measure responses from clinic stakeholders at each site. This is a standardized tool.
Reported challenges to implementationUp to 3 yearsIn qualitative interviews with stakeholders and on standardized forms, we will learn about major challenges to implementation across clinics and over time. These will be qualitative data.
Intervention adaptationsUp to 3 yearsIn qualitative interviews with stakeholders, we will learn whether there were any changes we need to be intended intervention components.
Clinic and provider factorsAt pre-intervention (1-2 years) and at the implementation midpoint (3-4 years)The Investigators will use EHR data to measure clinic size, location, staffing, resources, number of providers, number of patients to evaluate associations with successful intervention implementation.

Countries

United States

Contacts

CONTACTJessica Tuan
JTuan@mednet.ucla.edu310-825-3181
PRINCIPAL_INVESTIGATORFolasade P May, MD, PhD

UCLA / Jonsson Comprehensive Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026